2 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Pediatric ulcerative colitis: new trials by email Literature Review of Pediatric ulcerative colitis trials Research Report on Pediatric ulcerative colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis Vamorolone 4% suspension for oral dosing - Pediatric Ulcerative Colitis | Phase 1 / Phase 2 | Withdrawn | ReveraGen BioPharma, Inc. | 2020-09-01 | 2020-09-29 | |
| Lactobacillus GG in Pediatric Ulcerative Colitis (UC) Lactobacillus GG - Ulcerative Colitis | Phase 2 | Withdrawn | Children's Hospital Medical Center, Cincinnati | 2011-03-01 | 2017-02-07 |
Colitis (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Inflammatory Bowel Diseases (1) · Intestinal Diseases (1)
Suspensions (1) · VBP15 compound (1)
Children's Hospital Medical Center, Cincinnati (1) · ReveraGen BioPharma, Inc. (1)
United States (1)
Laurie Conklin, MD (1) · Lee Denson, M.D. (1)